For UK healthcare professionals only.
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found by clicking on the sponsors tab.
With evidence suggesting that over half of the UK population aged over 45 now has more than one long-term condition (LTC), the management of obesity, type 2 diabetes and the LTCs associated with them is growing ever more complex.
Despite the many challenges it faces, primary care is most strongly placed to provide effective, holistic care for these patients, in terms of both expertise and the relationship with the individual. This one-day conference from the Primary Care Diabetes & Obesity Society brought insights from the whole primary care multidisciplinary team to help healthcare professionals provide optimal care of multiple LTCs with the teams and the budgets they currently have.
Illustrated by cases at varying stages of their diabetes journey, the speakers summarise the best-practice management of a host of conditions and complications, including obesity, type 2 diabetes, severe mental illness, cardiovascular and renal disease, microvascular complications, liver disease and frailty.
You will learn not only what the latest guidelines recommend but also the principles that will allow them to provide the best possible care independent of new drug developments and the changing landscape of NHS services.
Slides and resources from the day are available below.
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia
Novo Nordisk has provided sponsorship to the PCDOS towards the running of this conference, in support of continued medical education, and has no influence over any of the sessions. Novo Nordisk has been granted stand space and will be present at the conference.
Sanofi has provided sponsorship towards this independent programme. Sanofi has had no input into the content of the programme or the choice of speakers. Sanofi will be present at the conference and exhibit with a company stand.
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found by clicking on the sponsors tab.
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
